Caroline Litchfield
Finanzdirektor/CFO bei IMMUNE DESIGN CORP
Vermögen: - $ am 30.04.2024
Aktive Positionen von Caroline Litchfield
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IMMUNE DESIGN CORP | Direktor/Vorstandsmitglied | 02.04.2019 | - |
Finanzdirektor/CFO | - | - | |
Treasurer | 02.04.2019 | - | |
MERCK & CO., INC. | Finanzdirektor/CFO | 01.04.2021 | - |
Treasurer | 01.01.2018 | 01.04.2021 |
Karriereverlauf von Caroline Litchfield
Ehemalige bekannte Positionen von Caroline Litchfield
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ORGANON & CO. | Direktor/Vorstandsmitglied | - | 31.05.2021 |
FULFORD (INDIA) LIMITED | Direktor/Vorstandsmitglied | 04.08.2013 | 30.01.2014 |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Finanzdirektor/CFO | - | 23.06.2009 |
Ausbildung von Caroline Litchfield
University of Leicester | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Vereinigtes Königreich | 3 |
Indien | 2 |
Operativ
Director of Finance/CFO | 3 |
Director/Board Member | 3 |
Treasurer | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
ORGANON & CO. | Health Technology |
Private Unternehmen | 3 |
---|---|
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Fulford (India) Ltd.
Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India. | Health Technology |
- Börse
- Insiders
- Caroline Litchfield
- Erfahrung